Vera Therapeutics (VERA) Research & Development (2020 - 2026)
Vera Therapeutics' Research & Development was $60.08 million in Q2 2026, up 3.2% from $58.2 million a year earlier but down 30.1% from the prior quarter.
Powered by 
Analysis
Vera Therapeutics (VERA) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vera Therapeutics' Research & Development was $261.87 million through Jun 30, 2026, up 51.3% year-over-year; for FY2025, it came in at $215.26 million, up 70.6% from FY2024.
- Research & Development has now increased for four consecutive years, with a five-year compound annual growth rate of 36.6% (FY2020 to FY2025).
- In earlier years, Research & Development was $126.17 million in FY2024 (+61.3%), $78.23 million in FY2023 (+13.4%), $68.99 million in FY2022 (+206.9%) and $22.48 million in FY2021 (-50.3%).
- Quarterly Research & Development has moved between $3.56 million (Q3 2021) and $86.01 million (Q1 2026) over five years.
- Compared with a year earlier, Research & Development has increased for nine straight quarters, with growth averaging 77.1% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 451.5%); the worst was Q4 2021 (a decline of 68.0%).
- Per Business Quant data, VERA's Research & Development in the three quarters before Q2 2026 was $86.01 million (Q1 2026), $59.31 million (Q4 2025) and $56.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Vera Therapeutics | 2.34 Bn | 2.34 Bn | - | 60.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.08 Mn |
| Mar 31, 2026 | 86.01 Mn |
| Dec 31, 2025 | 59.31 Mn |
| Sep 30, 2025 | 56.47 Mn |
| Jun 30, 2025 | 58.20 Mn |
| Mar 31, 2025 | 41.28 Mn |
| Dec 31, 2024 | 33.35 Mn |
| Sep 30, 2024 | 40.31 Mn |
| Jun 30, 2024 | 29.31 Mn |
| Mar 31, 2024 | 23.20 Mn |
| Dec 31, 2023 | 20.79 Mn |
| Sep 30, 2023 | 16.10 Mn |
| Jun 30, 2023 | 16.23 Mn |
| Mar 31, 2023 | 25.11 Mn |
| Dec 31, 2022 | 26.68 Mn |
| Sep 30, 2022 | 19.66 Mn |
| Jun 30, 2022 | 10.11 Mn |
| Mar 31, 2022 | 12.55 Mn |
| Dec 31, 2021 | 12.75 Mn |
| Sep 30, 2021 | 3.56 Mn |
API Access
Vera Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VERA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VERA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VERA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();